Growth Metrics

Adagio Medical Holdings (ADGM) EBIAT (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed EBIAT for 3 consecutive years, with -$4.6 million as the latest value for Q4 2025.

  • Quarterly EBIAT changed N/A to -$4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$26.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$24.3 million for FY2025, N/A changed from the prior year.
  • EBIAT for Q4 2025 was -$4.6 million at Adagio Medical Holdings, up from -$10.1 million in the prior quarter.
  • The five-year high for EBIAT was $3.6 million in Q3 2024, with the low at -$10.8 million in Q3 2023.
  • Average EBIAT over 3 years is -$6.2 million, with a median of -$7.7 million recorded in 2025.
  • The sharpest move saw EBIAT skyrocketed 133.51% in 2024, then plummeted 380.09% in 2025.
  • Over 3 years, EBIAT stood at -$8.6 million in 2023, then surged by 141.83% to $3.6 million in 2024, then crashed by 227.87% to -$4.6 million in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at -$4.6 million, -$10.1 million, and -$3.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.